China grants country’s first COVID-19 vaccine patent to CanSino, reports state media


Source: cnbctv18.com cnbctv18.com

Key Topics in this News Article:

News Snapshot:

The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on Aug. 11. Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries. CanSino's Hong Kong shares rose around 14 percent in Monday's morning session. Its Shanghai shares rose by 6.6 percent as of midday.